Which has the lower trailing P/E, ABBV or AMGN?

AMGN has the lower trailing P/E: ABBV trades at 72.43 and AMGN at 23.45. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or AMGN?

Over the past five years, AMGN grew revenue faster — ABBV at a 3.69% CAGR versus AMGN at 8.39%.

Does ABBV or AMGN pay a bigger dividend?

ABBV yields 2.68% and AMGN yields 2.56% based on trailing dividends and the latest price.

Is ABBV or AMGN more profitable?

AMGN runs the higher net margin — ABBV at 9.81% versus AMGN at 22.93%.

How have ABBV and AMGN total returns compared?

Over the past 10 years, ABBV delivered 19.76% and AMGN delivered 11.95% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Amgen Inc. (AMGN)

A side-by-side comparison of AbbVie Inc. and Amgen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

AMGN

Amgen Inc.

$203.66B

$377.35HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs AMGN

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)AMGN +201.9% (+11.7%/yr)ABBV compounded faster over this window

ABBV AMGN

ABBV vs AMGN: by the numbers

•ABBV is the larger company ($454.17B vs $203.66B market cap).
•AMGN trades at the lower trailing earnings multiple (23.45 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•AMGN converts more revenue to profit (22.93% vs 9.81% net margin).
•AMGN grew revenue faster over the past five years (8.39% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 2.56%).

Metrics side by side

Valuation

Metric	ABBV	AMGN
P/E ratio	72.43	23.45
Forward P/E	18.32	16.35
P/S ratio	7.05	5.34
P/B ratio	N/A	17.42
EV / EBITDA	19.34	N/A
FCF yield	3.99%	5.00%

Profitability

Metric	ABBV	AMGN
Gross margin	71.48%	72.65%
Operating margin	29.32%	33.18%
Net margin	9.81%	22.93%
ROE	N/A	74.80%
ROIC	13.46%	14.22%

Dividends

Metric	ABBV	AMGN
Dividend yield	2.68%	2.56%
Payout ratio	192.43%	60.91%

Growth (annualized)

Metric	ABBV	AMGN
Revenue CAGR (5Y)	3.69%	8.39%
EPS CAGR (5Y)	-2.79%	2.94%
FCF CAGR (5Y)	0.11%	-3.91%
Total return CAGR (5Y)	23.51%	15.90%

Frequently asked

Which has the lower trailing P/E, ABBV or AMGN?: AMGN has the lower trailing P/E: ABBV trades at 72.43 and AMGN at 23.45. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or AMGN?: Over the past five years, AMGN grew revenue faster — ABBV at a 3.69% CAGR versus AMGN at 8.39%.
Does ABBV or AMGN pay a bigger dividend?: ABBV yields 2.68% and AMGN yields 2.56% based on trailing dividends and the latest price.
Is ABBV or AMGN more profitable?: AMGN runs the higher net margin — ABBV at 9.81% versus AMGN at 22.93%.
How have ABBV and AMGN total returns compared?: Over the past 10 years, ABBV delivered 19.76% and AMGN delivered 11.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full AMGN analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Amgen P/E ratio AbbVie dividend yield Amgen dividend yield AbbVie ROE Amgen ROE AbbVie operating margin Amgen operating margin AbbVie revenue growth Amgen revenue growth AbbVie free cash flow Amgen free cash flow

AbbVie & Amgen appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.